AVTX 424B5: Shelf registration
Avalo Therapeutics
Filed with the SEC on · accession 0001104659-26-123069
AVTX filed a 424B5 (prospectus (offering)) with the SEC on Nov 5, 2026. The final terms of an offering of shares or bonds. The stock moved -6.2% by the first close after the filing.
Summary of the filing
Avalo Therapeutics entered into an Open Market Sale Agreement with Jefferies LLC to sell up to $200 million of common stock from time to time through an at-the-market offering.
Key details
How AVTX stock reacted
Close before
$7.07
Nov 4, 2026
First close after
-6.22%
$6.63
5 trading days
—
Since filing
—
✦ Ask GOAX AI about this filing — what it means for AVTX, what changed since its last filings and what to watch next.
Try it free for 7 days🔔 Want to stay updated on new SEC filings for AVTX?
Click hereFrequently asked questions
What did AVTX file with the SEC on Nov 5, 2026?
AVTX filed a 424B5 (Shelf registration). Avalo Therapeutics entered into an Open Market Sale Agreement with Jefferies LLC to sell up to $200 million of common stock from time to time through an at-the-market offering.
What does a shelf registration mean for AVTX stock?
New shares dilute existing holders and are often sold at a discount to the market price.
How do I read a 424B5?
The final terms of an offering of shares or bonds. Look at price, number of shares and the discount to the market price. Large offerings dilute existing shareholders.
Why are SEC filings important?
Public companies must tell the SEC about anything that can change their value — results, leadership changes, big deals, new shares, bankruptcy. Filings are the official source, often before the news. A 424B5 (prospectus (offering)): The final terms of an offering of shares or bonds.
How did AVTX stock react to this filing?
AVTX closed at $7.07 before the filing and $6.63 on Nov 5, 2026 (-6.22%).
Other AVTX SEC filings
Get alerts when AVTX files with the SEC, plus live charts, key levels and news for 13,000+ stocks.
Try SEPT free for 7 days